ARTICLE | Clinical News
Balacet 325 propoxyphene napsylate regulatory update
December 6, 2010 8:00 AM UTC
Cornerstone will withdraw its propoxyphene-containing pain drugs at FDA's request after new data showed that propoxyphene increases the risk for serious abnormal heart rhythms. Cornerstone's propoxyph...